Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and May 2026.
- Largest single sale: $1.1M (24,000 shares) of Veracyte, Inc. on May 22, 2026. Filing
- Last sale before this period: Dec 3, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | VP, Chief Accounting Officer | Mar 3, 2022 | Sep 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 2, 2026, Veracyte, Inc.: 1,361 shares withheld by the company for taxes. 1 filing: 1
- Jun 2, 2026, Veracyte, Inc.: 1,361 shares withheld by the company for taxes. 1 filing: 1
- May 22, 2026, Veracyte, Inc.: sold 24,000 shares for $1.1M, no plan disclosed; 24,000 shares acquired by exercising options. 1 filing: 1
- Mar 6, 2026, Veracyte, Inc.: 10,525 shares granted. 1 filing: 1
- Mar 2, 2026, Veracyte, Inc.: 3,006 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.